newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces $12.5 Million Private Placement

NEW YORK, June 14, 2021 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that it has executed securities purchase agreements to raise